14-3-3 antagonists for the prevention and treatment of...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) A61K 38/08 (2006.01) A61K 45/00 (2006.01) A61P 19/02 (2006.01) C07K 16/18 (2006.01) C12N 5/16 (2006.01)

Patent

CA 2706479

Methods for treating arthritis comprising 14-3-3 antagonists that are capable of specifically binding to extracellularly localized 14-3-3 eta and/or 14-3-3 gamma protein isoforms are provided. In preferred embodiments, the 14-3-3 antagonist is an inhibitory peptide or an anti-14- 3-3 antibody. The 14-3-3 antagonists are also formulated in a pharmaceutical composition and used in a method for reducing matrix metalloprotease (MMP) expression in the synovial fluid of a patient, wherein the MMP is MMP-1 or MMP-3.

L'invention propose des compositions et des procédés pour le traitement de l'arthrite.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

14-3-3 antagonists for the prevention and treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 14-3-3 antagonists for the prevention and treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 14-3-3 antagonists for the prevention and treatment of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1365216

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.